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Objective: Few will debate that infrainguinal arterial reconstruction increases limb salvage. However, numerous reports
describe a difference in results in coronary and peripheral arterial reconstructions between men and women. In this study,
we analyze the outcome of infrainguinal bypasses performed over 30 years and stratify the results by gender.
Methods: We reviewed our vascular registry from 1968 to 1999 for all infrainguinal arterial reconstructions. Demograph-
ics, indications, and adverse outcomes were analyzed. Patency, limb salvage, and survival rates were determined with
life-table analysis. The 2, log-rank, and Student t tests were used to determine statistical significance.
Results: Five thousand eight hundred eighty procedures were performed, with 2161 in women (37%). Women were
significantly older (71 versus 66 years), more often diabetic (53% versus 50%), and less often smokers (27% versus 44%)
and more often had surgery for limb salvage (89.8% versus 81.0%). Mortality, complications, and need for revision did
not differ. Primary patency rate was 44% versus 47%, secondary patency rate was 55% versus 58%, and survival rate was
39% versus 34% in men and women, respectively, at 10 years (all P > .05). Limb salvage rate in women exceeded that in
men (93% versus 88%) at 10 years. Subgroup analysis by conduit also revealed no difference in patency.
Conclusion: Infrainguinal arterial reconstruction can be performed safely with comparable results in women and men.
Although women may present older and more often for limb salvage, outcomes do not appear to be adversely affected. (J
Vasc Surg 2003;37:399-402.)
Numerous reports have established the durability and
efficacy of infrainguinal arterial reconstruction for limb
salvage.1-4 Further studies have analyzed efficacy in speci-
fied populations, including the very elderly and patients
with diabetes.5,6 The cardiology and cardiac surgery litera-
ture have suggested that women have higher morbidity and
mortality rates than men, lower graft patency, and similar
long-term survival.7-10 Several factors have been implicated
for this, including older age of presentation, more medical
comorbidity, and smaller vessel size.11,12
Does such a difference exist for infrainguinal arterial
reconstructions? The answer to this question has become
critical as women represent an increasing population of
patients undergoing lower limb revascularization. In 1993,
two conflicting reports were published. Magnant et al13
studied the outcome of 131 women undergoing infraingui-
nal bypass compared with male controls over 7 years and
concluded that the female gender negatively influences
patency but not limb salvage. Harris et al,14 in their series of
357 procedures performed in female patients, showed no
significant difference in graft patency, limb salvage, mortal-
ity, and long-term survival between the genders. Similar
findings were reported more recently by Belkin et al,15
comparing 10 years of in situ saphenous vein bypass with
490 patients. The purpose of this study was to review our
experience with infrainguinal arterial reconstructions to
determine whether gender affected outcome.
METHODS
Data related to all patients undergoing infrainguinal
arterial reconstruction (both primary and secondary proce-
dures) for whatever causes were stored prospectively in the
vascular registry between 1968 and 1999. Data included
patient demographics, risk factors, indications for revascu-
larization, inflow and outflow sources, bypass type, compli-
cations, revisions, patency rates, and survival.
Surgical technique involved a multiteam approach for
arterial dissection and vein harvest when the autologous
conduit was used. The in situ vein bypass was preferred
whenever ipsilateral greater saphenous vein was available.
After surgery, all patients were followed with noninva-
sive vascular laboratory assessment every 3 months for the
first year and every 6 months thereafter. A graft was defined
as patent on the basis of recommendations of the Ad Hoc
Committee on reporting standards of the Joint Council of
the Vascular Societies.16
Primary and secondary patency, limb salvage, and cu-
mulative survival rates were determined with life-table
methods. Differences in life-table results were compared
with the log-rank test of Mantel. Data were used only if the
standard error remained less than 10% of graft patency,
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limb salvage, or patient survival. The 2 analysis was used to
compare categoric parameters, and Student t test was used
to compare age between male and female patients.
The relationship between patency times and potential
influential variables was quantified with the Cox propor-
tional hazards model. Variables investigated included age at
surgery (in years), gender, presence of diabetes, history of
smoking, indication (tissue loss was the reference indica-
tion: claudication, rest pain, or aneurysm evaluated relative
to reference), graft type (prosthetic was the reference: in
situ vein, excised vein, or spliced vein evaluated with respect
to reference), presence of an infectious complication after
surgery, presence of a bleeding complication after surgery,
and the need for a revision.
RESULTS
From 1968 to 1999, 5880 infrainguinal arterial recon-
structions were performed at Albany Medical Center. Fol-
low-up period was at a mean of 25.0 months (range, 1 to
381 months). As seen in Table I, 2161 (36.8%) were
performed in female patients and 3719 (63.2%) in male
patients. The mean age was 71 years (range, 5 to 100 years)
in the female group and 66 years (range, 7 to 99 years) in
the male group (P .001). Diabetes was present in 53% of
the female group and 50% of the male group (P.03), and
smoking was found in only 27% of women and 44% of the
men (P  .001).
Indications for infrainguinal reconstructions are shown
in Table II. The most common indication for revascular-
ization was limb salvage under the setting of a nonhealing
ulcer, rest pain, or gangrene (89.8% for women and 81.0%
for men; P .001). Men underwent operation more often
for claudication (12.6% versus 8.3%; P  .001), peripheral
aneurysm (3.6% versus 0.1%; P  .001), and trauma (2.0%
versus 0.1%; P  .001). Our experience with women and
peripheral aneurysms is extremely low.
The inflow arteries, outflow arteries, and type of con-
duit are summarized in Table III. The most common
inflow was from the common femoral artery in both female
and male groups (43% and 36%, respectively). There was no
difference between genders in the use of either in situ,
excised, or prosthetic conduit. The in situ bypass was
preferred and used in 55% of both groups.
As far as 30-day complications related to the graft, there
was no overall difference in the rate among female or male
patients (9.7% versus 8.4%; P .10). Mortality also did not
differ, with a 3.5% rate in women versus a 2.9% rate in men
(P  .17). A more detailed listing of graft-related compli-
cations can be seen in Table IV. Wound infections (defined
as a complication that prolongs length of stay or necessi-
tates readmission) were higher in women (4.1%) than in
men (2.9%; P  .01). Cardiac complications in women
(3.9%) significantly exceeded those seen in men (2.4%; P
.001).
Revisions during the life of the graft (after the initial
30-day postoperative period) were necessary in an equal
number of men and women. That is, 13.8% of women and
13.5% of men underwent some form of graft intervention.
The most common was repair of the venous conduit (4.4%
versus 4.7%) followed by ligation of an arteriovenous fistula
(2.9% versus 2.5%) and outflow revision (2.4% versus
2.0%). This is summarized in Table V.
Table I. Demographics
Female Male P value
Total procedures 2161 (36.8%) 3719 (63.2%)
Diabetes 1146 (53.0%) 1859 (50.0%) .03
Smoking history 590 (27.3%) 1,625 (43.7%) .001
Average age (y) 71  12.12 66  11.92 .001
Table II. Indications
Female Male P value
Claudication 180 (8.3%) 468 (12.6%) .001
Embolic 23 (1.1%) 31 (0.8%) .37
Critical ischemia 1941 (89.8%) 3013 (81.0%) .001
Gangrene 457 (21.2%) 797 (21.4%) .80
Ulcer 808 (37.4%) 1238 (33.3%) .002
Rest pain 676 (31.3%) 978 (26.3%) .001
Trauma 15 (0.7%) 74 (2.0%) .001
Aneurysm 2 (0.1%) 132 (3.6%) .001
Table III. Inflow/outflow sources
Female Male P value
Inflow source
Iliac/graft 218 (10.1%) 398 (10.7%) .81
Common femoral 921 (42.6%) 1349 (36.3%) .001
Superior femoral 519 (24.0%) 1040 (28.0%) .001
Deep femoral 334 (15.5%) 543 (14.6%) .37
Popliteal 144 (6.7%) 333 (9.0%) .002
Tibial 25 (1.2%) 56 (1.5%) .27
Outflow source
Above-knee popliteal 368 (17.0%) 568 (15.3%) .08
Below-knee popliteal 531 (24.6%) 795 (21.4%) .005
Tibial 1057 (48.9%) 2036 (54.8%) .001
Proximal tibial 751 (34.8%) 1421 (38.2%) .008
Distal tibial 342 (15.8%) 615 (16.5%) .48
Dorsalis pedis 169 (7.8%) 320 (8.6%) .30
Bypass type
In situ 1197 (55.4%) 2065 (55.5%) .92
Excised vein 553 (25.6%) 1003 (27.0%) .25
Prosthetic 411 (19.0%) 651 (17.5%) .14
Table IV. Operative mortality/complications
Female Male P value
Operative mortality 76 (3.5%) 107 (2.9%) .17
Complications Total 209 (9.7%) 313 (8.4%) .10
Bleeding 52 (2.4%) 74 (2.0%) .28
Wound infection 89 (4.1%) 107 (2.9%) .01
Graft infection 9 (0.4%) 21 (0.6%) .47
Retained valve 19 (0.9%) 45 (1.2%) .24
Immediate limb loss 40 (1.9%) 68 (1.8%) .96
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Table VI (online only) summarizes primary patency,
and Table VII (online only) shows secondary patency. The
overall primary patency rate in men at 5 and 10 years was
61% and 44% and in women was 65% and 47%, respectively.
The overall secondary patency rate at 5 and 10 years in men
was 70% and 55% and in women was 74% and 58%, respec-
tively. Log-rank analysis revealed no difference between the
male and female groups overall. When subgroups were
compared on the basis of conduit (in situ vein, excised vein,
and prosthetic), no difference was identified. Belkin et al15
had shown a difference in patency rate at the tibial level. We
therefore compared between the gender all bypasses done
with tibial outflow. Primary patency rate (47% versus 47%),
secondary patency rate (58% versus 60%), and limb salvage
rate (84% versus 93%) all at 10 years were not statistically
different between men and women, respectively, in our
series.
Overall limb salvage is reported in Table VIII (online
only). Limb salvage at 10 years in the male group was 88%
and in the female group was 93% (P  .05). In subgroup
analysis, the in situ (96% versus 89%) and the prosthetic
(94% versus 87%) groups also had female patients superior
to male patients at 10 and 6 years, respectively. The only
group in which there was no significant difference was that
of the excised vein group, where limb salvage was 90% at 8
years in both genders.
Table IX (online only) relates patient survival rates.
These were no different in both subgroup and overall
analyses. At 10 years, survival rate was seen at 39% in the
male group and at 34% in the female group. We also
assessed survival on the basis of gender and diabetes. At 10
years, both male patients (88% versus 51%) and female
patients (87% versus 42%) had a significantly lower survival
rate, with patients with diabetes compared with those with-
out, respectively. No statistical difference was present in
survival rate between male diabetic patients and female
diabetic patients at 10 years (51% versus 42%).
Results of Cox proportional hazard regression analysis
are presented in Table X (online only). The relative hazards
(relative risk) results indicate that, when considered sepa-
rately, only diabetes, smoking history, and the presence of
rest pain or aneurysm as an indication had statistically
significant effects on patency rate (95% CIs, not including
one). Multivariate analysis with the Cox proportional haz-
ards model adjusted for age, diabetes, smoking, and other
covariates indicated that gender had a nonsignificant effect
on patency. When stepwise regression was used (F to enter,
F to remove both set to 0.10), then diabetes, smoking, rest
pain, and aneurysm were seen to have an effect on patency
when considered together (Table XI, online only). In a
backward stepping procedure, female gender was the last
variable to be eliminated. The results of female gender
forced into the Cox regression model are listed in Table XI
(online only). Thus, in neither univariate Cox proportional
hazards regression model was gender a significant predictor
on patency. When other variables were not considered,
female gender was found to have a relative hazards for
occlusion of 0.98 (95% CI, 0.85, 1.13). When other statis-
tically significant predictors of patency were included (dia-
betes, smoking, indication of rest pain, or indication of
aneurysm), then gender still did not have a statistically
significant effect (multivariate hazards ratio of 0.89; 95%
CI, 0.76, 1.03).
DISCUSSION
In the Western world, women outlive men. Over the
last 30 years, the proportion of women undergoing lower
limb revascularization has increased significantly from 15%
to 37% in our experience. Some reports suggest that
women have worse outcomes once vascular disease has
become symptomatic. Is it the nature of the disease, the
hormonal biology, or physiologic limitations from arterial
size?
Significant gender difference has been reported in pa-
tients with symptomatic coronary artery disease.7-12 How-
ever, the role of gender on outcome of infrainguinal bypass
remains controversial. Magnant et al13 found a significant
reduction in both long-term survival and graft patency,
leading to the conclusion that female gender was a signifi-
cant negative predictor of outcome after infrainguinal re-
construction. Enzler and Ruoss17 from Zurich identified
lower patency rates in women compared with men. These
results were not corroborated in our data. Some of this may
be explained by a high incidence rate of patients with
chronic critical ischemia in their series and perhaps more
overall atherosclerosis negatively affecting outcomes. Bel-
kin et al15 in a more recent review on in situ bypasses
showed that limb salvage was similar in both groups as were
patency and survival. However, in this series, women
tended to have significantly worse secondary patency in
distal tibial reconstructions and early perioperative wound
complications. The latter was also seen in our series where
we noted the wound complication rate for women was 4.1%
compared with 2.9% in men. Other manuscripts have iden-
tified the female gender as a risk factor for incisional mor-
bidity.18,19 However, our analysis with bypasses with tibial
outflow did not show any difference in primary or second-
ary patency rate at 10 years of follow-up.
Mays et al20 noted that women had a higher incidence
rate of perioperative myocardial infarction and a lower
long-term survival rate than men. Although all patients in
our study had the same preoperative cardiac evaluation, we
Table V. Revisions
Female Male P value
Total 298 (13.7%) 501 (13.5%) .73
Ligation of arteriovenous
fistula
62 (2.9%) 92 (2.5%) .35
Valve excision 19 (0.9%) 45 (1.2%) .24
Inflow 40 (1.9%) 59 (1.6%) .46
Outflow 51 (2.4%) 74 (2.0%) .34
Venous conduit 94 (4.4%) 176 (4.7%) .50
Thrombectomy 23 (1.1%) 42 (1.1%) .80
Thrombolytic treatment 7 (0.3%) 10 (0.3%) .73
Aneurysm excision 2 (0.1%) 3 (0.1%) .90
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noted over a 60% increase in perioperative cardiac compli-
cations in women when compared with men, 3.9% to 2.4%,
respectively (P  .001). Hendel et al21 showed that al-
though men undergoing distal revascularization had more
cardiac disease identified before surgery with electrocardio-
gram and dipyridamole thallium stress testing, women had
a higher incidence rate of postoperative myocardial infarc-
tions. Unfortunately, there are little objective data for
explanation of this phenomenon. Some have hypothesized
that women may have a different distribution of their
disease or that their cardiac disease is poorly identified with
nuclear imaging techniques.
Consistent throughout these series is the fact that
women present at an older age and are less often smokers.
The clinical difference in the incidence rate of diabetes is
probably small. Also seen in our series was a higher preva-
lence rate of chronic critical ischemia at presentation by
more than 10%. We believe that women do present later
and with more diffuse disease. Estrogen may be their pro-
tection until menopause, after which atherosclerotic disease
rapidly develops and they thereby show symptoms later in
years. Given the significantly lower rate of tobacco abuse,
smoking is probably not the cause for the higher athero-
sclerotic plaque burden. In addition, we can identify no
form of referral bias. However, these data also indicate that
even at such late time of presentation the outcomes did not
differ. Despite the presumed anatomic limitation of smaller
blood vessels and more extensive disease, reconstructive
efforts have yielded excellent results, with limb salvage rates
over 90% even in the subset of tibial artery bypass. In
follow-up, revision rates between men and women are
similar, and their secondary outcomes are equivalent.
Again, these data were confirmed by Harris et al,14 Frangos
et al,19 and Belkin et al.15 Even after early graft failure,
Robinson et al22 found no difference related to gender in
outcome.
In conclusion, our data show that infrainguinal arterial
reconstructions can be performed with comparable results
in men and women. Although women may present at a
more advanced age and more often for limb salvage, out-
comes do not appear to be adversely affected.
We thank Paul Feustel, PhD, for help with the statistical
analysis in this manuscript.
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Table VI, online only. Primary patency
Interval
(mo) Grafts at risk Withdrawn
Occlusions/
revisions
Interval
patency
Cumulative
patency Standard error
Male
0-1 3719 544 253 0.9266 0.9266 0.004
2-12 2922 1101 322 0.8642 0.8008 0.007
13-24 1499 387 110 0.9157 0.7333 0.010
25-36 1002 276 57 0.9340 0.6849 0.012
37-48 669 160 32 0.9457 0.6477 0.015
49-60 477 127 26 0.9371 0.6070 0.017
61-72 324 68 16 0.9448 0.5735 0.021
73-84 240 60 11 0.9476 0.5435 0.024
85-96 169 34 9 0.9408 0.5113 0.028
97-108 126 27 6 0.9467 0.4840 0.031
109-120 93 32 7 0.9091 0.4400 0.034
Female
0-1 2161 251 160 0.9214 0.9214 0.006
2-12 1750 690 181 0.8712 0.8027 0.010
13-24 879 250 50 0.9337 0.7495 0.014
25-36 579 152 24 0.9523 0.7137 0.017
37-48 403 90 18 0.9497 0.6778 0.020
49-60 295 67 11 0.9579 0.6493 0.024
61-72 217 63 9 0.9515 0.6178 0.028
73-84 145 34 8 0.9375 0.5792 0.033
85-96 103 30 2 0.9773 0.5660 0.040
97-108 71 11 6 0.9084 0.5142 0.044
109-120 54 18 4 0.9111 0.4685 0.051
Table VII, online only. Secondary patency
Interval
(mo) Grafts at risk Withdrawn
Occlusions/
revisions
Interval
patency
Cumulative
patency Standard error
Male
0-1 3718 553 169 0.9509 0.9509 0.004
2-12 2996 1158 224 0.9073 0.8628 0.006
13-24 1614 429 92 0.9343 0.8061 0.009
25-36 1093 306 44 0.9532 0.7683 0.011
37-48 743 178 30 0.9541 0.7331 0.014
49-60 535 144 21 0.9546 0.6998 0.017
61-72 370 80 14 0.9576 0.6701 0.020
73-84 276 70 11 0.9544 0.6396 0.023
85-96 195 42 6 0.9655 0.6175 0.027
97-108 147 28 7 0.9474 0.5850 0.031
109-120 112 38 5 0.9462 0.5535 0.035
Female
0-1 2161 257 115 0.9434 0.9434 0.005
2-12 1789 724 123 0.9138 0.8621 0.009
13-24 942 267 38 0.9530 0.8216 0.012
25-36 637 166 15 0.9729 0.7993 0.015
37-48 456 105 18 0.9554 0.7637 0.019
49-60 333 76 8 0.9729 0.7430 0.022
61-72 249 74 10 0.9528 0.7079 0.026
73-84 165 42 5 0.9653 0.6833 0.032
85-96 118 32 2 0.9804 0.6699 0.038
97-108 84 14 6 0.9221 0.6177 0.044
109-120 64 21 3 0.9439 0.5831 0.052
Table VIII, online only. Limb salvage
Interval
(mo) Grafts at risk Withdrawn
Occlusions/
revisions
Interval
patency
Cumulative
patency Standard error
Male
0-1 3719 646 68 0.9800 0.9800 0.002
2-12 3005 1327 67 0.9714 0.9519 0.004
13-24 1611 501 16 0.9882 0.9407 0.006
25-36 1094 340 8 0.9913 0.9326 0.007
37-48 746 204 3 0.9953 0.9283 0.009
49-60 539 162 4 0.9913 0.9201 0.011
61-72 373 93 1 0.9969 0.9173 0.014
73-84 279 79 3 0.9875 0.9058 0.017
85-96 197 48 0 1.0000 0.9058 0.020
97-108 149 35 0 1.0000 0.9058 0.023
109-120 114 40 3 0.9681 0.8769 0.029
Female
0-1 2161 328 40 0.9800 0.9800 0.003
2-12 1793 822 28 0.9797 0.9601 0.005
13-24 943 303 1 0.9987 0.9589 0.006
25-36 639 179 3 0.9945 0.9537 0.008
37-48 457 122 1 0.9975 0.9513 0.010
49-60 334 82 1 0.9966 0.9480 0.012
61-72 251 83 1 0.9952 0.9435 0.014
73-84 167 47 0 1.0000 0.9435 0.017
85-96 120 34 0 1.0000 0.9435 0.021
97-108 86 19 1 0.9869 0.9312 0.026
109-120 66 24 0 1.0000 0.9312 0.030
Table IX, online only. Survival
Interval
(mo) Grafts at risk Withdrawn
Occlusions/
revisions
Interval
patency
Cumulative
patency Standard error
Male
0-1 3718 615 107 0.9686 0.9686 0.003
2-12 2996 1184 198 0.9176 0.8888 0.005
13-24 1614 422 99 0.9294 0.8261 0.009
25-36 1093 277 73 0.9235 0.7629 0.011
37-48 743 164 44 0.9334 0.7122 0.014
49-60 535 121 44 0.9073 0.6461 0.017
61-72 370 64 30 0.9112 0.5888 0.020
73-84 276 59 22 0.9108 0.5362 0.022
85-96 195 40 8 0.9543 0.5117 0.026
97-108 147 26 9 0.9328 0.4773 0.028
109-120 112 24 19 0.8100 0.3866 0.029
Female
0-1 2161 296 76 0.9622 0.9622 0.004
2-12 1789 702 145 0.8992 0.8652 0.008
13-24 942 238 67 0.9186 0.7948 0.012
25-36 637 152 29 0.9483 0.7537 0.015
37-48 456 87 36 0.9127 0.6879 0.018
49-60 333 65 19 0.9368 0.6444 0.021
61-72 249 54 30 0.8649 0.5573 0.023
73-84 165 36 11 0.9252 0.5156 0.028
85-96 118 23 11 0.8967 0.4624 0.031
97-108 84 12 8 0.8974 0.4150 0.035
109-120 64 14 10 0.8246 0.3422 0.035
Table X, online only. Cox proportional hazards regression analysis
Variable Hazards ratio 95% CI
Diabetes 3.78 3.25 4.40*
Age (per year) 0.970 0.965 0.976
Female gender 0.977 0.846 1.129
Smoking 0.775 0.667 0.900*
Indication (relative to tissue loss)
Claudication 0.80 0.64 1.00
Rest pain 0.80 0.68 0.94*
Aneurysm 0.44 0.25 0.79*
Graft type (relative to prosthetic)
In situ 1.05 0.87 1.29
Excised 1.02 0.82 1.28
Spliced 1.28 0.91 1.80
Prosthetic compared with all vein types 0.97 0.81 1.17
Infectious Complication 1.12 0.74 1.67
Bleeding Complication 0.92 0.55 1.52
Revision performed 0.89 0.69 1.14
*Denotes significant impact on graft patency.
Table XI, online only. Multivariate Analysis with Cox proportional hazards model and stepwise regression and
backward stepping* with regard to patency
Variable Hazards ratio 95% CI P value
Stepwise regression
Diabetes 3.732 3.206 4.345 .001
Smoking 0.782 0.673 0.908 .001
Rest pain 0.862 0.733 1.013 .066
Aneurysm 0.539 0.301 0.967 .034
Backward stepping
Gender 0.890 0.767 1.031 .111
Diabetes 3.743 3.216 4.358 .001
Smoking 0.766 0.658 0.892 .001
Rest pain 0.869 0.739 1.022 .084
Aneurysm 0.518 0.289 0.931 .034
*Forcing female gender into model.
